Sumitomo Mitsui Trust Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
AW
Sumitomo Mitsui Trust Group's ABMD Position: Q4 2022 in Review
Sumitomo Mitsui Trust Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 129,450 shares — an estimated $31.8M sold.
Sumitomo Mitsui Trust Group first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $69.1M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Sumitomo Mitsui Trust Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Sumitomo Mitsui Trust Group sold 129,450 Abiomed Inc shares in Q4 2022, an estimated $31.8M.
- Sumitomo Mitsui Trust Group first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
- Sumitomo Mitsui Trust Group's Abiomed Inc position peaked at $69.1M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2022, filed 30 Jan 2023.